Boditech Med Inc. (KOSDAQ:206640)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,650
-270 (-2.09%)
At close: Feb 6, 2026
-22.11%
Market Cap275.56B -26.0%
Revenue (ttm)151.75B +7.0%
Net Income27.23B -0.3%
EPS1,250.34 +0.7%
Shares Out21.78M
PE Ratio10.12
Forward PEn/a
Dividend150.00 (1.19%)
Ex-Dividend DateMar 31, 2025
Volume89,902
Average Volume68,908
Open12,790
Previous Close12,920
Day's Range12,200 - 12,790
52-Week Range12,200 - 18,670
Beta0.32
RSI44.22
Earnings DateFeb 13, 2026

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;... [Read more]

Sector Healthcare
Founded 1998
Employees 541
Stock Exchange KOSDAQ
Ticker Symbol 206640
Full Company Profile

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.

Financial Statements